All results
7 results for progress phase i and open label randomized controlled phase ii study testing safety
-
Clinical Trials
The investigators want to study if lower doses of chemotherapy will help babies with SCID to achieve good immunity with less short and long-term risks of…
-
News, Stories & Blog
Part 2 of our “Year in Review” focuses on the hospitals, research institutes and centers that are part of the UF Health family: UF Health Cancer Center UF…
-
News, Stories & Blog
Part 2 of our “Year in Review” focuses on the hospitals, research institutes and centers that are part of the UF Health family: UF Health Cancer Center UF…
-
News, Stories & Blog
Marking the first year of the Power of Together strategic plan, 2015 was a tremendous year of continued growth and progress for UF Health. In this…
-
Clinical Trials
This is a Phase 2, randomized, double-blind, placebo-controlled, multicenter study of ALXN2050 (120 and 180 milligrams [mg]) in addition to background therapy…
-
Clinical Trials
The objective of the trial is to assess the long-term safety and efficacy of L-CsA plus Standard of Care (SoC) in the treatment of BOS in single (SLT) and…
-
News, Stories & Blog
Part 2 of our “year in review” focuses on the hospitals, research institutes and centers that are part of the UF Health family. When added to the colleges…